Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.
/* OVERVIEW */ ?>
Avida Global Rating Review
Pitch rating powered by CROWDRATING™
Rated on 02/07/2021
Log in to view target
£15,446,959
pre-money valuation
6.08%
equity available
565
investors
£2,914
pledge per investor
11540240
company number
Active
company status
28/08/2018
incorporated 6 years
Previous Funding rounds
29 Mar 24 | Seedrs | £1,646,249 / 165% | 79.33% |
Officers
Mark Stevens MCVEIGH
Appointed: 10-10-2017
Mark Stevens MCVEIGH
Appointed: 08-12-2016
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 03-10-2008
Mark Stevens MCVEIGH
Appointed: 01-05-2007
Mark Stevens MCVEIGH
Appointed: 24-04-2007
Mark Stevens MCVEIGH
Appointed: 28-03-2007
Mark Stevens MCVEIGH
Appointed: 28-03-2007
Mark Stevens MCVEIGH
Appointed: 28-03-2007
Mark Stevens MCVEIGH
Appointed: 28-03-2007
Mark Stevens MCVEIGH
Appointed: 27-03-2007
Mark Stevens MCVEIGH
Appointed: 20-09-2006
Mark Stevens MCVEIGH
Appointed: 20-09-2006
Mark Stevens MCVEIGH
Appointed: 06-01-2006
Mark Stevens MCVEIGH
Appointed: 14-09-2005
Mark Stevens MCVEIGH
Appointed: 21-04-2004
Mark Stevens MCVEIGH
Appointed: 15-07-2003
Mark Stevens MCVEIGH
Appointed: 15-07-2003
Mark Stevens MCVEIGH
Appointed: 15-07-2003
Mark Stevens MCVEIGH
Appointed: 09-07-2003
Mark Stevens MCVEIGH
Appointed: 20-12-2002
Mark Stevens MCVEIGH
Appointed: 01-12-2002
News
Avida Global enters UK cannabis market - Business of Cannabis -
01/12/2022 Business of Cannabis -
Avida Global to manufacture medical cannabis products in the UK - Cannabis Health News
01/12/2022 Cannabis Health News
UK-based Avida Global, a medicinal cannabis oils startup, raises €1.2 million via Seedrs equity crowdfunding campaign - EU-Startups
11/06/2021 EU-Startups
Avida Global acquires Canna Creations and Green Stem CBD - Business of Cannabis -
23/04/2023 Business of Cannabis -
Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global - Yahoo Finance
07/09/2022 Yahoo Finance
UK cannabis firm Avida Global acquires leading CBD producer - Cannabis Health News
30/09/2021 Cannabis Health News
What the ratings mean
RISK WARNING - The ratings are based on the information provided in the fund raiser’s pitch deck, business plans and financial forecasts which have appeared on a FCA regulated crowdfunding site. Where possible we validate the business plan to public sources such as LinkedIn, Companies House, Credit Agencies and internet searches. We cannot guarantee the information is correct. The ratings report takes no account of the investors/ individual circumstances. Do your own due diligence and get professional advice before investing. Your capital is at risk when investing in private companies.